BATCH DOCUMENTATION

Find your batch report.

Search by compound or the full lot number on your vial. Each report applies only to the listed lot and configuration.

Reports shown: 6

Thymosin Alpha-1 10 mgLot: TA1-0825-01View batch COA

Celltechgen Laboratory · Report approved September 9, 2026 · CTG08242602

When enlarged, scroll sideways to read the report.
Thymosin Alpha-1 10 mg, TA1-0825-01. Watermarked batch report reference copy; client label added by Limitless.
Reported test results
TestReport specificationReported resultTest date
Potency90%–110%Pass · 104.53%2026-09-04
Purity95%–100%Pass · 99.99%2026-09-04
EndotoxinPass/FailPass · 12.5 EU/mL2026-09-03

Report note: potency testing is referenced by standards only. Method development, validation, and stability testing were not ordered for this finished product at Celltechgen Lab.

These results apply to the listed lot only. Research use only. Not for human or veterinary use.

Back to product — 10 mg
BPC-157 10 mgLot: BPC157-0825-01View batch COA

Celltechgen Laboratory · Report approved September 9, 2026 · CTG08242603

When enlarged, scroll sideways to read the report.
BPC-157 10 mg, BPC157-0825-01. Watermarked batch report reference copy; client label added by Limitless.
Reported test results
TestReport specificationReported resultTest date
Potency90%–110%Pass · 108.13%2026-09-04
Purity95%–100%Pass · 99.68%2026-09-04
EndotoxinPass/FailPass · 12.5 EU/mL2026-09-03

Report note: potency testing is referenced by standards only. Method development, validation, and stability testing were not ordered for this finished product at Celltechgen Lab.

These results apply to the listed lot only. Research use only. Not for human or veterinary use.

Back to product — 10 mg
DSIP 10 mgLot: DSP260513View batch COA

Celltechgen Laboratory · Report approved September 9, 2026 · CTG08242605

The supplied report spells the description "DISP". Limitless identifies this lot as DSIP; the report wording is unchanged.

When enlarged, scroll sideways to read the report.
DSIP 10 mg, DSP260513. Watermarked batch report reference copy; client label added by Limitless.
Reported test results
TestReport specificationReported resultTest date
Potency90%–110%Pass · 108.56%2026-09-04
Purity95%–100%Pass · 98.87%2026-09-04
EndotoxinPass/FailPass · 1.25 EU/mL2026-09-03

Report note: potency testing is referenced by standards only. Method development, validation, and stability testing were not ordered for this finished product at Celltechgen Lab.

These results apply to the listed lot only. Research use only. Not for human or veterinary use.

Back to product — 10 mg
3GLP / Retatrutide 20 mgLot: RETA20-0825-01View batch COA

Celltechgen Laboratory · Report approved September 9, 2026 · CTG08242607

The description field is blank in the supplied report. Limitless identifies lot RETA20-0825-01 as Retatrutide 20 mg; the report is unchanged.

When enlarged, scroll sideways to read the report.
3GLP / Retatrutide 20 mg, RETA20-0825-01. Watermarked batch report reference copy; client label added by Limitless.
Reported test results
TestReport specificationReported resultTest date
Potency90%–110%Pass · 96.38%2026-09-04
Purity95%–100%Pass · 98.665%2026-09-04
EndotoxinPass/FailPass · 50 EU/mL2026-09-03

Report note: potency testing is referenced by standards only. Method development, validation, and stability testing were not ordered for this finished product at Celltechgen Lab.

These results apply to the listed lot only. Research use only. Not for human or veterinary use.

Back to product — 20 mg
3GLP / Retatrutide 40 mgLot: RETA-0825-01View batch COA

Celltechgen Laboratory · Report approved September 9, 2026 · CTG08242608

When enlarged, scroll sideways to read the report.
3GLP / Retatrutide 40 mg, RETA-0825-01. Watermarked batch report reference copy; client label added by Limitless.
Reported test results
TestReport specificationReported resultTest date
Potency90%–110%Pass · 93.54%2026-09-04
Purity95%–100%Pass · 99.315%2026-09-04
EndotoxinPass/FailPass · 100 EU/mL2026-09-03

Report note: potency testing is referenced by standards only. Method development, validation, and stability testing were not ordered for this finished product at Celltechgen Lab.

These results apply to the listed lot only. Research use only. Not for human or veterinary use.

Back to product — 40 mg
SS-31 50 mgLot: SS31-0825-01View batch COA

Celltechgen Laboratory · Report approved September 9, 2026 · CTG08242610

When enlarged, scroll sideways to read the report.
SS-31 50 mg, SS31-0825-01. Watermarked batch report reference copy; client label added by Limitless.
Reported test results
TestReport specificationReported resultTest date
Potency90%–110%Pass · 109.74%2026-09-04
Purity95%–100%Pass · 99.96%2026-09-04
EndotoxinPass/FailPass · 12.5 EU/mL2026-09-03

Report note: potency testing is referenced by standards only. Method development, validation, and stability testing were not ordered for this finished product at Celltechgen Lab.

These results apply to the listed lot only. Research use only. Not for human or veterinary use.

Back to product — 50 mg

Need help matching a lot?

Contact us